پرش به محتوا
ابزار کمک‌تصمیم برای کادر درمان — جایگزین قضاوت بالینی نیست
دگزامد
→بازگشت به لیست همه دپارتمان‌های کشیک
15 پروتکل بالینی استاندارد · ۱۰۰٪ ژنریک INN

پکیج کشیک

کتاب مرجع اصلی:

هیپرکالمی شدید و تهدیدکننده حیات با اختلالات الکتروکاردیوگرافیک

(Severe Life-Threatening Hyperkalemia with Electrocardiographic Derangements)
ICD-10: E87.5مرجع: Brenner & Rector's The Kidney - Ch. 17

📋 نکات شرح حال (History Pearls):

  • •Severe electrolyte elevation & precipitants: Serum potassium > 6.5 mEq/L (or > 6.0 mEq/L with rapid escalation or acute ECG changes) in patients with acute kidney injury, advanced chronic kidney disease, severe tissue catabolism (rhabdomyolysis, tumor lysis syndrome), or massive hemolysis
  • •Pharmacologic triggers & diet: Exposure to potassium-sparing agents (Spironolactone, Eplerenone, Amiloride, Triamterene), ACE inhibitors, Angiotensin Receptor Blockers, Direct Renin Inhibitors, NSAIDs, Trimethoprim, Calcineurin inhibitors (Cyclosporine, Tacrolimus), or potassium-containing salt substitutes
  • •Neuromuscular prodrome: Ascending symmetric muscle weakness starting in lower extremities, severe flaccid quadriparesis, hyporeflexia, paresthesias, nausea, and paralytic ileus; cerebral sensorium is characteristically preserved until cardiovascular collapse

🩺 معاینه فیزیکی (Physical Exam):

  • •Neuromuscular examination: Symmetric flaccid paralysis, diminished or absent deep tendon reflexes, preserved cranial nerve function, and absence of sensory level
  • •Hemodynamic instability: Severe sinus bradycardia, junctional escape rhythm, marked hypotension, cool pale extremities, and impending cardiac arrest
  • •Volume status evaluation: Assess for signs of extracellular fluid overload (jugular venous distension, pulmonary rales, ascites, peripheral anasarca) versus severe prerenal hypovolemia

🧪 آزمایشگاه و تصویربرداری:

  • •Sequential 12-Lead ECG Progression: Earliest sign: tall, peaked, narrow, symmetrical T waves with short QT interval (K+ 5.5-6.5 mEq/L); progressive changes: PR interval prolongation, flattening and loss of P waves (sinoventricular conduction), ST-segment depression (K+ 6.5-7.5 mEq/L); late critical changes: widening of QRS complex (> 120 ms), blending of QRS into T wave forming a biphasic 'sine-wave' pattern, ventricular fibrillation, or asystole (K+ > 8.0 mEq/L)
  • •Laboratory panel & blood gas: Serum potassium confirmation via stat non-hemolyzed blood sample (rule out pseudohyperkalemia from traumatic phlebotomy, prolonged tourniquet time, in vitro thrombocytosis > 500,000/uL, or leukocytosis > 50,000/uL); arterial or venous blood gas showing metabolic acidosis which shifts potassium extracellularly (0.1 fall in pH raises serum K+ by 0.3-0.5 mEq/L); BUN, creatinine, calcium, magnesium, and serum creatine kinase
  • •Urinary potassium parameters: Spot urine potassium, urine osmolality, and transtubular potassium gradient (TTKG < 6-7 indicates impaired aldosterone-mediated renal potassium excretion)

💊 دستورات بستری و درمانی (Generic INN):

  • ✓Diet/Activity: Strict NPO; strict potassium-free diet (0 mEq K+); absolute bed rest with continuous 12-lead ECG telemetry monitoring in an Intensive Care or Resuscitation Unit; establish two large-bore peripheral IV access lines; mobilize nephrology consult immediately for emergent hemodialysis
  • ✓Monitoring: Continuous cardiac telemetry, cycling non-invasive blood pressure every 5 minutes during acute resuscitation, continuous pulse oximetry, Foley catheter for strict hourly urine output; repeat serum potassium and venous blood gas at 30, 60, and 120 minutes post-intervention; continuous rhythm strip monitoring for widening QRS or sine waves
  • ✓IV Hydration: Avoid all potassium-containing IV fluids (Lactated Ringer's, Plasma-Lyte); if hypovolemic, infuse 0.9% Normal Saline or 1.2% Isotonic Sodium Bicarbonate (150 mEq in 1000 mL 5% Dextrose) at 150-250 mL/hr to promote kaliuresis; strictly avoid fluid overloading in oliguric renal failure
  • ✓Pharmacotherapy (Generic Only): MEMBRANE STABILIZATION (Step 1 - Immediate Antidote for ECG changes or K+ > 6.5 mEq/L): Calcium Gluconate 10% 10 to 20 mL (1 to 2 grams) IV over 2 to 5 minutes (or Calcium Chloride 10% 10 mL [1 gram] IV via central or large-bore peripheral vein in frank shock or cardiac arrest; provides 3-fold higher elemental calcium); onset 1-3 minutes, lasts 30-60 minutes; repeat dose after 5-10 minutes if ECG changes persist; INTRACELLULAR POTASSIUM SHIFTING (Step 2 - Temporary Redirection): Regular Insulin 10 units IV rapid push accompanied immediately by 50 mL 50% Dextrose in Water (D50W / 25 grams dextrose) over 5 minutes (maintain 10% Dextrose infusion at 50-75 mL/hr for 4-6 hours to prevent late hypoglycemia); onset 15-30 minutes, reduces K+ by 0.5-1.2 mEq/L; PLUS Nebulized Albuterol 10 to 20 mg (in 4 mL saline) inhaled over 15 minutes (beta-2 adrenergic stimulation shifts K+ via Na/K-ATPase; additive with insulin); PLUS Sodium Bicarbonate 50 to 100 mEq (1-2 ampules) IV over 5 minutes if severe concurrent metabolic acidosis (pH < 7.20); POTASSIUM ELIMINATION / REMOVAL (Step 3 - Definitive Body Depletion): Loop Diuretic kaliuresis: Furosemide 40 to 80 mg IV (or up to 160-200 mg IV in advanced CKD) if kidneys produce urine; GASTROINTESTINAL POTASSIUM BINDERS: Sodium Zirconium Cyclosilicate 10 g orally dissolved in water three times daily for 48 hours OR Patiromer 8.4 to 16.8 g orally once daily with food OR Sodium Polystyrene Sulfonate 15 to 30 g orally suspended in water (strictly avoid sorbitol combinations due to intestinal necrosis); DEFINITIVE EMERGENCE HEMODIALYSIS: Stat emergent hemodialysis is the definitive gold standard treatment for refractory hyperkalemia, severe oliguric kidney failure, ongoing tissue breakdown, or failure of medical temporization

⚠️ علائم خطر حیات (Red Flags):

  • !Administering insulin without concurrent 50% Dextrose or failing to monitor blood glucose for 4-6 hours post-administration, resulting in severe fatal hypoglycemic coma and seizure
  • !Failing to administer intravenous Calcium immediately when ECG demonstrates widened QRS, absent P waves, or sine-wave morphology, allowing progression to ventricular fibrillation or asystole
  • !Administering Sodium Polystyrene Sulfonate mixed with Sorbitol, precipitating extensive transmural intestinal ischemia, bowel necrosis, and fatal colon perforation

آسیب حاد کلیه مرحله ۳ کیدیگو و اندیکاسیون‌های درمان اورژانس جایگزینی کلیه

(Acute Kidney Injury KDIGO Stage 3 and Indications for Emergent Renal Replacement Therapy)
ICD-10: N17.9مرجع: Brenner & Rector's The Kidney - Ch. 31

📋 نکات شرح حال (History Pearls):

  • •KDIGO Stage 3 diagnostic definition: 3.0-fold increase in serum creatinine from baseline, or acute rise in serum creatinine to >= 4.0 mg/dL (>= 353.6 mcmol/L), or initiation of renal replacement therapy, OR severe oliguria/anuria: urine output < 0.3 mL/kg/hr for >= 24 hours, or absolute anuria for >= 12 hours
  • •Etiologic category screening: Prerenal hypoperfusion (septic shock, hemorrhage, severe dehydration, cardiorenal/hepatorenal failure); Intrinsic renal injury (acute tubular necrosis from prolonged ischemia or nephrotoxins, acute interstitial nephritis, glomerulonephritis, atheroembolism); Postrenal obstruction (prostatic hypertrophy, bilateral ureteral obstruction, neurogenic bladder)
  • •Uremic toxic symptoms: Progressive anorexia, nausea, intractable vomiting, metallic taste in mouth, severe pruritus, hiccups, asterixis, cognitive slowing, uremic somnolence, or bleeding diathesis (uremic platelet dysfunction)

🩺 معاینه فیزیکی (Physical Exam):

  • •Volume status differentiation: Extracellular fluid overload: elevated jugular venous pressure, bilateral basal inspiratory crackles, gallop rhythm (S3), hepatomegaly, and peripheral/presacral anasarca; Intravascular depletion: postural hypotension, dry mucous membranes, sunken eyes, collapsed non-distended jugular veins
  • •Uremic stigmata & pericardial rub: Uremic pericardial friction rub (scratchy, superficial, triphasic sound heard over left sternal border; pathognomonic for urgent dialysis); asterixis (flapping tremor); myoclonus; uremic frost over skin
  • •Bladder & pelvic examination: Palpable distended suprapubic bladder dull to percussion; digital rectal examination for prostatic enlargement; pelvic exam for gynecologic masses obstructing ureters

🧪 آزمایشگاه و تصویربرداری:

  • •Urinary Indices & Microscopic Urinalysis: Centrifuged urine sediment microscopy (cardinal test): muddy-brown granular casts and renal tubular epithelial cell casts diagnostic of Acute Tubular Necrosis; white blood cell casts and eosinophils indicating Acute Interstitial Nephritis; dysmorphic RBCs and RBC casts indicating Glomerulonephritis; Fractional Excretion of Sodium (FeNa < 1% favors prerenal; FeNa > 2% indicates intrinsic ATN; note: FeNa can be < 1% in contrast nephropathy, pigment nephropathy, and acute glomerulonephritis); Fractional Excretion of Urea (FeUrea < 35% useful if diuretics given)
  • •Serial Metabolic & Blood Gas Panel: Serum creatinine, BUN, BUN/creatinine ratio; serum potassium, calcium, phosphate, magnesium, uric acid; arterial blood gas showing high anion gap metabolic acidosis (pH < 7.15, HCO3 < 10-12 mEq/L)
  • •Urgent Renal Ultrasonography: Bilateral renal ultrasound performed within 12 hours to rule out hydronephrosis/postrenal obstruction (calyceal dilation, hydroureter), assess renal parenchymal echogenicity, and confirm normal kidney size (> 10-12 cm; small contracted kidneys indicate pre-existing chronic kidney disease)

💊 دستورات بستری و درمانی (Generic INN):

  • ✓Diet/Activity: Renal diet: sodium restriction (2 g/day), potassium restriction (< 40-50 mEq/day), phosphate restriction (< 800-1000 mg/day); protein intake 1.2-1.5 g/kg/day during catabolic AKI (higher if on continuous renal replacement therapy: 1.5-2.0 g/kg/day); bed rest; avoid nephrotoxins
  • ✓Monitoring: Intensive Care Unit admission; continuous cardiac telemetry; strict hourly urine output via Foley catheter (closed drainage system); daily weights; serial electrolytes, BUN, creatinine, and arterial blood gas every 6 to 12 hours; continuous hemodynamic monitoring (arterial line)
  • ✓IV Hydration: GOAL-DIRECTED RESUSCITATION: If fluid responsive (dynamic parameters: passive leg raise, stroke volume variation), infuse balanced crystalloids (Plasma-Lyte or 0.9% Normal Saline) at 200-300 mL/hr to restore effective circulating arterial volume; STOP IV FLUIDS once euvolemia is achieved; STRICT RESTRICTION in fluid overloaded oliguric/anuric patients (insensible losses 500 mL/day plus measured urine and drainage output)
  • ✓Pharmacotherapy (Generic Only): DISCONTINUE NEPHROTOXINS: Immediately discontinue all NSAIDs, ACE inhibitors, ARBs, aminoglycosides, vancomycin (or adjust to levels), and iodinated radiocontrast; FUROSEMIDE STRESS TEST (FST - To predict progression and dialysis requirement in euvolemic AKI): Administer Furosemide 1.0 mg/kg IV in loop diuretic-naive patients (or 1.5 mg/kg IV in patients with prior loop exposure); failure to achieve > 200 mL of urine output within 2 hours defines a failed FST and predicts severe progressive AKI requiring renal replacement therapy; URGENT INDICATIONS FOR RENAL REPLACEMENT THERAPY ('AEIOU' Triad): 1. Acidosis: severe metabolic acidosis (pH < 7.15) refractory to medical bicarbonate; 2. Electrolytes: severe refractory hyperkalemia (K+ > 6.5 mEq/L or sine waves) unresponsive to medical shift therapy; 3. Ingestion/Intoxication: dialyzable toxins (lithium, ethylene glycol, methanol, salicylates); 4. Overload: severe refractory hypervolemic pulmonary edema non-responsive to diuretics; 5. Uremia: overt uremic complications (uremic encephalopathy, uremic pericarditis, uremic bleeding); MODALITY SELECTION: Intermittent Hemodialysis (IHD) for hemodynamically stable patients; Continuous Renal Replacement Therapy (CRRT - CVVH/CVVHD/CVVHDF) for hemodynamically unstable, septic, or multi-organ failure patients in ICU; VASCULAR ACCESS: Placement of a non-tunneled, dual-lumen hemodialysis catheter into right internal jugular vein under real-time ultrasound guidance

⚠️ علائم خطر حیات (Red Flags):

  • !Continuing aggressive crystalloid fluid boluses in an oliguric or anuric patient without fluid responsiveness, triggering fatal pulmonary edema, severe hypoxia, and abdominal compartment syndrome
  • !Delaying the initiation of emergency hemodialysis in the presence of uremic pericarditis or uremic encephalopathy, risking cardiac tamponade, refractory arrhythmias, and death
  • !Failing to immediately relieve postrenal obstructive hydronephrosis with emergency Foley catheterization, percutaneous nephrostomy, or ureteral stenting, causing irreversible parenchymal atrophy

سندرم هپاتورنال با آسیب حاد کلیه (HRS-AKI) و پروتکل وازوکانستریکتور و آلبومین

(Hepatorenal Syndrome Acute Kidney Injury (HRS-AKI) and Vasoconstrictor-Albumin Protocol)
ICD-10: K76.7مرجع: Brenner & Rector's The Kidney - Ch. 33

📋 نکات شرح حال (History Pearls):

  • •Diagnostic criteria for HRS-AKI (International Club of Ascites): Diagnosis of cirrhosis with ascites; acute kidney injury meeting KDIGO criteria (serum creatinine increase >= 0.3 mg/dL within 48 hours or >= 50% from baseline); NO improvement of serum creatinine after at least 48 hours of diuretic withdrawal and intravascular volume expansion with 20% Albumin (1 g/kg/day); absence of shock; no current or recent exposure to nephrotoxic drugs; absence of macroscopic signs of structural kidney injury
  • •Precipitating events: Severe spontaneous bacterial peritonitis (SBP), large-volume paracentesis without adequate albumin replacement, gastrointestinal bleeding, aggressive diuretic over-titration, or non-SBP systemic infections
  • •Pathophysiologic mechanism: Extreme splanchnic arterial vasodilation secondary to nitric oxide excess leading to severe arterial underfilling, intense compensatory renal vasoconstriction via renin-angiotensin-aldosterone and sympathetic nervous systems, and profound renal hypoperfusion

🩺 معاینه فیزیکی (Physical Exam):

  • •Cirrhotic & portal hypertensive examination: Tense ascites, shifting dullness, severe jaundice, spider angiomata, palmar erythema, caput medusae, splenomegaly, and bilateral peripheral edema
  • •Hemodynamic status: Systemic arterial hypotension (baseline Mean Arterial Pressure frequently 60-70 mmHg), bounding peripheral pulses, resting tachycardia, warm extremities due to hyperdynamic circulation and low systemic vascular resistance
  • •Neurological & uremic assessment: Asterixis, cognitive slowing or delirium indicating hepatic encephalopathy; lack of frank uremic pericardial friction rub

🧪 آزمایشگاه و تصویربرداری:

  • •Urinary Indices & Absence of Structural Injury: Marked renal sodium retention: spot urine sodium typically < 10-15 mEq/L with Fractional Excretion of Sodium (FeNa < 0.2-0.5%); urine osmolality higher than plasma osmolality; benign, bland urine sediment (absence of muddy brown granular casts, absence of hematuria or RBC casts; proteinuria < 500 mg/day); novel tubular injury biomarkers (urinary NGAL) are low/normal in pure HRS-AKI compared to intrinsic ATN
  • •Metabolic panel & dilutional hyponatremia: Rising serum creatinine (note: baseline serum creatinine in cirrhosis is deceptively low due to severe muscle wasting, sarcopenia, and reduced hepatic creatine synthesis; a creatinine of 1.2-1.5 mg/dL often represents GFR < 30 mL/min); severe dilutional hyponatremia (serum sodium 120-130 mEq/L) from impaired free water clearance; elevated BUN
  • •Diagnostic paracentesis & renal ultrasound: MANDATORY diagnostic paracentesis to definitively exclude spontaneous bacterial peritonitis (ascitic PMN < 250 cells/mm3); renal ultrasound demonstrating anatomically normal kidneys with normal cortical echogenicity and no hydronephrosis

💊 دستورات بستری و درمانی (Generic INN):

  • ✓Diet/Activity: Sodium restriction to 2 g/day (88 mEq/day); fluid restriction to 1000-1200 mL/day only if serum sodium < 125 mEq/L; bed rest; WITHDRAW ALL DIURETICS: Immediately stop Spironolactone, Furosemide, and all antihypertensive agents; discontinue non-selective beta-blockers; strictly avoid all NSAIDs, aminoglycosides, and radiocontrast
  • ✓Monitoring: Intensive Care Unit or Step-Down Unit monitoring; continuous arterial line blood pressure monitoring to track Mean Arterial Pressure (MAP target: increase MAP by >= 10-15 mmHg from baseline); strict hourly urine output via Foley catheter; daily body weight; serial serum creatinine, electrolytes, and arterial lactate every 12-24 hours; monitor for signs of volume overload and pulmonary edema from albumin therapy
  • ✓IV Hydration: MANDATORY INITIAL VOLUME CHALLENGE: 20% or 25% Albumin at 1 g/kg/day IV (maximum 100 g/day) for 48 consecutive hours with complete cessation of diuretics; if creatinine does not improve after 48 hours and structural disease is excluded, the diagnosis of HRS-AKI is confirmed and vasoactive therapy is initiated
  • ✓Pharmacotherapy (Generic Only): FIRST-LINE VASOCONSTRICTOR (Gold Standard Medical Therapy): Terlipressin 1 mg IV bolus every 4 to 6 hours (or continuous IV infusion starting at 2 mg/day and titrated up to 12 mg/day); if serum creatinine does not decrease by >= 25% after 3 days, increase Terlipressin dose to 2 mg IV every 4 hours; continue until complete response (serum creatinine returns to within 0.3 mg/dL of baseline) or maximum 14 days; CONCURRENT ALBUMIN THERAPY: Co-administer 20% Albumin 20 to 40 grams IV daily throughout Terlipressin therapy; MONITOR FOR ISCHEMIA: Monitor for Terlipressin-induced peripheral digital cyanosis, intestinal ischemia, and severe pulmonary edema (stop infusion if severe hypoxemia or ischemia occurs); ALTERNATIVE VASOCONSTRICTOR (ICU setting where Terlipressin unavailable): Norepinephrine continuous IV infusion starting at 0.5 mg/hr (0.1 mcg/kg/min) titrated upward to achieve an increase in Mean Arterial Pressure of at least 15 mmHg or MAP > 85 mmHg, combined with 20% Albumin 20-40 g/day IV; ORAL ALTERNATIVE (Non-ICU setting): Midodrine 7.5 to 12.5 mg orally three times daily PLUS Octreotide 100 to 200 mcg subcutaneously three times daily (or 50 mcg/hr IV) combined with 20% Albumin (inferior efficacy to Terlipressin or Norepinephrine); DEFINITIVE CURATIVE TREATMENT: Immediate referral for urgent Orthotopic Liver Transplantation (or combined Liver-Kidney Transplantation if renal failure duration > 6-8 weeks); Renal Replacement Therapy (CRRT preferred) as a bridge to transplant

⚠️ علائم خطر حیات (Red Flags):

  • !Continuing loop or potassium-sparing diuretics in a cirrhotic patient with rising creatinine, precipitating severe irreversible renal cortical ischemia and death
  • !Failing to recognize that baseline serum creatinine of 1.0-1.2 mg/dL in a sarcopenic cirrhotic patient may represent advanced GFR reduction (< 30 mL/min), delaying HRS recognition
  • !Over-infusing intravenous Albumin in patients receiving Terlipressin without respiratory monitoring, resulting in fatal acute pulmonary edema and severe hypoxic respiratory failure

هیپوناترمی حاد علامت‌دار شدید و پروتکل سالین هیپرتونیک

(Severe Symptomatic Acute Hyponatremia and Hypertonic Saline Protocol)
ICD-10: E87.1مرجع: Brenner & Rector's The Kidney - Ch. 16

📋 نکات شرح حال (History Pearls):

  • •Acuteness of onset & severe neurological symptoms: Serum sodium < 120-125 mEq/L (often < 115 mEq/L) accompanied by life-threatening neurological manifestations (generalized tonic-clonic seizures, coma, respiratory arrest, obtundation) secondary to acute cellular cerebral edema and increased intracranial pressure
  • •Etiologic category & rapid water loading: Acute water intoxication: endurance athletes / marathon runners consuming excessive hypotonic fluids, psychogenic polydipsia, MDMA ('Ecstasy') intoxication (stimulates both massive water ingestion and potent non-osmotic vasopressin release), post-transurethral resection of prostate (TURP syndrome with glycine irrigation), postoperative hypotonic IV fluid administration; Chronic hyponatremia: thiazide diuretics, SIADH, heart failure, cirrhosis, adrenal insufficiency
  • •Chronicity differentiation: Acute (< 48 hours onset; brain has not yet extruded intracellular osmoles and is at high risk of fatal herniation, but ZERO risk of osmotic demyelination syndrome); Chronic (> 48 hours or unknown duration; brain has extruded intracellular potassium and organic osmoles [myo-inositol, taurine] to restore volume, making it extremely vulnerable to Osmotic Demyelination Syndrome [ODS / central pontine myelinolysis] if corrected too rapidly)

🩺 معاینه فیزیکی (Physical Exam):

  • •Neurological emergency examination: Depressed Glasgow Coma Scale, stupor, unarousable coma, generalized epileptic seizures or status epilepticus, decorticate or decerebrate posturing, bilateral dilated or sluggish pupils, and signs of impending uncal/tonsillar brain herniation
  • •Extracellular volume status evaluation: Hypovolemic: dry mucous membranes, decreased skin turgor, orthostatic hypotension, flat jugular veins; Euvolemic: normal skin turgor, moist mucous membranes, normal blood pressure, absence of peripheral edema (typical for SIADH); Hypervolemic: jugular venous distension, pulmonary rales, ascites, marked peripheral/presacral pitting edema
  • •Respiratory pattern: Cheyne-Stokes respiration, hypoventilation, hypercapnia, or neurogenic non-cardiogenic pulmonary edema

🧪 آزمایشگاه و تصویربرداری:

  • •Stat Serum & Urine Osmolality and Electrolytes: Stat serum sodium, serum osmolality (true hypotonic hyponatremia: serum osmolality < 275-280 mOsm/kg; rule out pseudohyponatremia from severe hypertriglyceridemia or paraproteinemia, and hypertonic translocational hyponatremia from severe hyperglycemia: corrected Na = measured Na + 0.016 x [glucose - 100]); spot urine sodium and spot urine osmolality (urine osmolality > 100 mOsm/kg indicates impaired water excretion / ADH action; urine Na > 30-40 mEq/L in euvolemic SIADH, urine Na < 20-30 mEq/L in hypovolemia or hypervolemic effective volume depletion)
  • •Endocrine & Organ Function Workup: Serum thyroid stimulating hormone (TSH) to rule out severe myxedema; serum morning cortisol or cosyntropin stimulation test to rule out acute primary or secondary adrenal insufficiency; serum potassium, BUN, creatinine, and uric acid (serum uric acid < 4 mg/dL strongly supports SIADH)
  • •Neuroimaging (Stat Non-Contrast Head CT): Performed to evaluate cerebral edema (diffuse effacement of sulci and basilar cisterns), exclude acute intracranial hemorrhage, brain mass, or cerebellar tonsillar herniation

💊 دستورات بستری و درمانی (Generic INN):

  • ✓Diet/Activity: Strict NPO; bed rest with seizure precautions (padded bed rails, suction apparatus, oxygen at bedside); immediate airway evaluation and elective endotracheal intubation if Glasgow Coma Scale <= 8, persistent seizures, or loss of airway protective reflexes; strict fluid restriction (< 500 mL/day)
  • ✓Monitoring: Intensive Care Unit admission; continuous arterial line or automated blood pressure monitoring, continuous cardiac telemetry; STAT serum sodium measurements every 1 to 2 hours during active hypertonic saline administration, and every 4 hours once acute symptoms resolve; strict hourly Foley catheter urine output monitoring (spontaneous free water diuresis indicates sudden drop in ADH and heralds rapid overcorrection risk)
  • ✓IV Hydration: Avoid all hypotonic crystalloids (5% Dextrose, 0.45% Saline); if severe active neuro-symptoms (seizures, coma), initiate 3% Hypertonic Saline immediately; RESTRICTIVE RATE OF CORRECTION LIMITS: In chronic hyponatremia, the maximum safe rate of serum sodium correction is strictly 8 mEq/L in any 24-hour period (and <= 6 mEq/L in 24 hours for patients at high risk of osmotic demyelination: chronic alcoholism, malnutrition, advanced cirrhosis, hypokalemia, initial Na < 105 mEq/L); in acute hyponatremia (< 48 hours), faster correction (4-6 mEq/L in first few hours) is safe and urgently required to halt cerebral herniation
  • ✓Pharmacotherapy (Generic Only): EMERGENCY 3% HYPERTONIC SALINE PROTOCOL FOR ACTIVE SEIZURES / COMA: 3% Hypertonic Saline (513 mEq/L sodium) 100 mL IV bolus infused over 10 minutes; if seizures or severe neurological symptoms persist, repeat 100 mL IV bolus of 3% Hypertonic Saline over 10 minutes up to two additional times (total 300 mL maximum); TARGET: Elevate serum sodium acutely by 4 to 6 mEq/L within the first 1 to 2 hours, which is sufficient to reduce cerebral brain volume by 10% and arrest life-threatening herniation and seizures; once severe symptoms resolve, STOP hypertonic saline boluses and transition to strict maintenance restriction or very slow 3% infusion (0.5-1 mL/kg/hr); MANAGEMENT OF ACCIDENTAL OVERCORRECTION (> 8 mEq/L in 24 hours): If spontaneous water diuresis causes sodium to rise too rapidly, IMMEDIATELY HALT all active sodium administration; infuse 5% Dextrose in Water (D5W) at 3-10 mL/kg/hr IV to match urinary water losses PLUS administer Desmopressin 1 to 2 mcg IV or subcutaneously every 6 to 8 hours to clamp urinary free water excretion and re-lower serum sodium below the safe 8 mEq/24hr threshold

⚠️ علائم خطر حیات (Red Flags):

  • !Exceeding the safe correction rate of 8 mEq/L in 24 hours in chronic hyponatremia, causing irreversible Osmotic Demyelination Syndrome (central pontine myelinolysis), spastic quadriparesis, pseudobulbar palsy, 'locked-in' syndrome, and death
  • !Failing to recognize sudden spontaneous dilute polyuria (water diuresis) when the underlying cause of SIADH or hypovolemia resolves, triggering rapid catastrophic overcorrection
  • !Administering normal saline (0.9% NaCl) in SIADH patients with high urine osmolality (> 500 mOsm/kg), causing paradoxical worsening of hyponatremia due to renal excretion of hypertonic urine ('desalination')

هیپرناترمی شدید ناشی از دیابت بی‌مزه مرکزی و کمبود آب آزاد

(Severe Hypernatremia secondary to Central Diabetes Insipidus and Free-Water Deficit)
ICD-10: E23.2مرجع: Brenner & Rector's The Kidney - Ch. 16

📋 نکات شرح حال (History Pearls):

  • •Severe hypertonicity & free-water loss: Serum sodium > 155-160 mEq/L (hyperosmolar state > 320-340 mOsm/kg) resulting from pure free water deficit caused by deficient synthesis or secretion of Arginine Vasopressin (AVP / antidiuretic hormone) by the hypothalamic-neurohypophyseal system
  • •Etiologic neurosurgical & traumatic triggers: Recent transsphenoidal pituitary surgery (classic triphasic response: initial polyuria for 1-5 days, transient SIADH for 1-5 days, followed by permanent or transient diabetes insipidus), severe closed head trauma with basilar skull fracture, pituitary apoplexy, craniopharyngioma, intracranial tumors, granulomatous infiltration (sarcoidosis, histiocytosis X), or hypoxic-ischemic brain injury
  • •Polyuria-Polydipsia syndrome: Abrupt onset of massive polyuria (urine volume > 3 to 10 Liters/day, often 200-500 mL/hr) of clear, dilute, water-like urine; intense unquenchable thirst (polydipsia) with a strong craving for ice-cold water; hypernatremia develops when the patient loses access to water, becomes immobilized, or has impaired thirst perception

🩺 معاینه فیزیکی (Physical Exam):

  • •Neurological manifestation of cellular dehydration: Confusion, extreme irritability, agitation, neuromuscular excitability, hyperreflexia, spasticity, progressing to stupor, coma, and focal neurological deficits; intracranial bridging veins are placed under severe mechanical tension by shrinking brain parenchyma, predisposing to subdural hematoma and subarachnoid hemorrhage
  • •Volume and hydration parameters: Severe dehydration stigmata: parched, dry oral mucosa, furrowed tongue, doughy skin turgor, sunken eyeballs; hemodynamic instability (hypotension, tachycardia) develops if free water deficit is accompanied by concurrent extracellular solute losses
  • •Urine appearance: Persistently copious, crystal-clear, dilute urine output despite severe clinical dehydration and elevated serum sodium

🧪 آزمایشگاه و تصویربرداری:

  • •Serum and Urine Osmolality Discrepancy: Marked elevation of serum sodium (> 150-165 mEq/L) and serum osmolality (> 315-340 mOsm/kg) paired paradoxically with dilute urine: spot urine osmolality < 200-300 mOsm/kg (characteristically lower than plasma osmolality) and low urine specific gravity (< 1.005); urine sodium typically < 20-30 mEq/L
  • •Desmopressin Challenge Test (Distinguishing Central from Nephrogenic DI): Administer Desmopressin 2 to 4 mcg subcutaneously or IV; in Central Diabetes Insipidus, urine osmolality increases by > 50-100% within 1 to 2 hours alongside an abrupt drop in urine volume; in complete Nephrogenic Diabetes Insipidus (renal resistance to ADH), urine osmolality fails to rise by > 50%
  • •Free Water Deficit Calculation: Free Water Deficit (FWD) = Total Body Water x [(Serum Na / 140) - 1], where Total Body Water is estimated as body weight (kg) multiplied by 0.6 (young males), 0.5 (young females/elderly males), or 0.45 (elderly females); this calculated deficit must be replaced along with ongoing hourly urinary free water losses

💊 دستورات بستری و درمانی (Generic INN):

  • ✓Diet/Activity: Unrestricted access to oral water if patient is conscious and has intact swallowing/thirst reflexes; for sedated, intubated, or altered patients, enterally infuse sterile free water via nasogastric tube (enteral water replacement is safer and more physiologic than IV hypotonic solutions); bed rest; avoid physical restraint
  • ✓Monitoring: Intensive Care Unit admission; continuous arterial line blood pressure monitoring; continuous cardiac telemetry; strict hourly urine output via Foley catheter (crucial to measure ongoing hourly urine volume to replace ongoing free water losses!); stat serum sodium and blood glucose every 2 to 4 hours; daily body weight
  • ✓IV Hydration: HYPOTONIC FLUID RESUSCITATION: If enteral water cannot be administered, infuse 5% Dextrose in Water (D5W) IV or 0.45% Saline; RESTRICTIVE RATE OF CORRECTION LIMITS: The rate of serum sodium reduction must NOT exceed 0.5 mEq/L/hr or 10-12 mEq/L in any 24-hour period; rapid correction of hypernatremia induces rapid osmotic brain swelling, cerebral edema, uncal herniation, and death (as the brain generates idiogenic intracellular osmoles over 48 hours to protect volume)
  • ✓Pharmacotherapy (Generic Only): SPECIFIC REPLACEMENT THERAPY (Central Diabetes Insipidus): Desmopressin 1.0 to 2.0 mcg IV or subcutaneously every 12 hours (titrated to achieve urine volume of 1.5 to 2.5 L/day and urine osmolality > 400 mOsm/kg); alternatively, Desmopressin oral tablets 0.1 to 0.2 mg orally every 8-12 hours or Desmopressin nasal spray 10 mcg intranasally once or twice daily; HOURLY FREE WATER REPLACEMENT FORMULA: Hourly IV fluid rate = (Calculated 24-hour Free Water Deficit / 48 hours) + Measured Previous Hour Urine Output + Insensible Losses (30-40 mL/hr); adjust D5W infusion hourly to prevent hypernatremic overshoot or rapid hypoosmolar collapse; AVOID RAPID HYPERGLYCEMIA: Monitor blood glucose during D5W infusion; add low-dose regular insulin if blood glucose > 200 mg/dL to prevent glucosuria-induced osmotic diuresis

⚠️ علائم خطر حیات (Red Flags):

  • !Lowering serum sodium by more than 10-12 mEq/L in a 24-hour period, precipitating catastrophic cerebral edema, seizure, brain herniation, and irreversible neurologic devastation
  • !Failing to measure and replace ongoing hourly dilute urine losses, resulting in progressive hypernatremic dehydration and cardiovascular collapse despite administering static baseline fluid orders
  • !Administering repeated large doses of Desmopressin without checking serum sodium and urine output, trapping water and causing rapid fatal hyponatremia with acute brain swelling

سندرم کاردیورنال نوع ۱ با احتقان مقاوم و مقاومت به دیورتیک

(Cardiorenal Syndrome Type 1 with Refractory Decompensated Congestion and Diuretic Resistance)
ICD-10: I50.9مرجع: Brenner & Rector's The Kidney - Ch. 32

📋 نکات شرح حال (History Pearls):

  • •Pathophysiologic definition: Acute worsening of cardiac function (acute decompensated heart failure, cardiogenic shock) precipitating secondary acute kidney injury (KDIGO stage 1-3) driven primarily by severe renal venous congestion (elevated central venous pressure transmission to renal veins) and reduced renal perfusion pressure
  • •Escalating congestion & diuretic failure: Progressive severe exertional dyspnea, orthopnea, paroxysmal nocturnal dyspnea, rapid fluid weight gain (> 5-10 kg), and worsening peripheral anasarca despite escalating doses of outpatient oral loop diuretics (diuretic resistance)
  • •Underlying cardiac pathology: Ischemic cardiomyopathy, severe non-ischemic dilated cardiomyopathy, acute myocardial infarction, severe valvular regurgitation/stenosis, or acute decompensation of heart failure with preserved ejection fraction (HFpEF)

🩺 معاینه فیزیکی (Physical Exam):

  • •Severe systemic & pulmonary venous congestion: Elevated jugular venous distension (> 10-12 cm H2O with positive hepatojugular reflux), bilateral coarse pulmonary crackles/rales, pleural effusions (dullness to percussion), third heart sound (S3 gallop), tender congestive hepatomegaly, ascites, and severe bilateral lower extremity/scrotal pitting anasarca
  • •Hemodynamic profile (Stevenson hemodynamic classification): Predominantly 'Warm and Wet' (well-perfused with massive congestion) or 'Cold and Wet' (poorly perfused, narrow pulse pressure, cold mottled extremities, low cardiac output with massive congestion)
  • •Blood pressure parameters: Systolic blood pressure variable; hypotension (systolic BP < 90 mmHg) indicates cardiogenic shock or profound low-output state requiring inotropic support rather than isolated diuresis

🧪 آزمایشگاه و تصویربرداری:

  • •Biochemical profile & worsening renal function: Acute rise in serum creatinine (increase >= 0.3 mg/dL or >= 50% from baseline) and BUN; serum electrolytes demonstrating hypochloremia and hyponatremia (predicts severe neurohormonal activation and diuretic resistance); hyperuricemia; elevated serum cardiac biomarkers (NT-proBNP markedly elevated, elevated high-sensitivity troponin)
  • •Spot Urine Sodium & Diuretic Response Metric: Spot urine sodium measured 2 hours after loop diuretic administration: spot urine Na < 50-70 mEq/L (or 6-hour urine volume < 100-150 mL/hr) defines diuretic resistance and predicts poor decongestion and adverse renal outcomes
  • •Bedside Echocardiography & Lung Ultrasound (POCUS): Transthoracic echocardiogram demonstrating severely reduced left ventricular ejection fraction (or severe diastolic dysfunction), dilated right ventricle with severe tricuspid regurgitation, severely dilated and non-collapsible inferior vena cava (IVC > 2.1 cm with < 50% inspiratory collapse indicating central venous pressure > 15-20 mmHg); lung ultrasound showing diffuse bilateral B-lines ('lung rockets')

💊 دستورات بستری و درمانی (Generic INN):

  • ✓Diet/Activity: Strict sodium restriction to 2 g/day (88 mEq/day); fluid restriction to 1.5 L/day; strict bed rest with head elevated 45 degrees; daily morning body weight on the same scale
  • ✓Monitoring: Intensive Care Unit or Cardiac Step-Down admission; continuous ECG telemetry; continuous non-invasive or arterial line blood pressure monitoring; Foley catheter with hourly urine output measurement; serial serum creatinine, BUN, potassium, and sodium every 12-24 hours; invasive central venous pressure or pulmonary artery catheterization (Swan-Ganz) if hemodynamic status is uncertain or refractory to medical therapy
  • ✓IV Hydration: STRICT CESSATION OF MAINTENANCE CRYSTALLOIDS; crystalloid volume expansion will aggravate pulmonary alveolar flooding, raise renal venous pressures, and worsen glomerular filtration; target negative net fluid balance of 2 to 3 Liters per 24 hours until clinical decongestion is achieved
  • ✓Pharmacotherapy (Generic Only): HIGH-DOSE STEPWISE INTRAVENOUS LOOP DIURETIC PROTOCOL: Furosemide continuous IV infusion (start with IV bolus equivalent to 2.5 times the oral home dose, e.g., 80-160 mg IV bolus, followed by 10-20 mg/hr continuous IV infusion, titrated up to 40 mg/hr) OR Bumetanide 2 to 4 mg IV bolus followed by 1-2 mg/hr infusion; SEQUENTIAL NEPHRON BLOCKADE (To overcome diuretic resistance in distal tubule): Add Metolazone 5 to 10 mg orally once daily (or Chlorothiazide 500 mg IV twice daily) administered 30 minutes prior to loop diuretic; PLUS Acetazolamide 500 mg IV once daily (blocks proximal tubular bicarbonate and sodium reabsorption, improving decongestion and overcoming hypochloremic alkalosis); SGLT2 INHIBITOR (Cardiorenal Protection): Empagliflozin 10 mg orally once daily or Dapagliflozin 10 mg orally once daily once hemodynamically stable; INOTROPIC THERAPY (For 'Cold and Wet' low-output cardiogenic hypoperfusion with SBP < 90 mmHg): Dobutamine continuous IV infusion 2.5 to 7.5 mcg/kg/min (increases cardiac index and improves renal perfusion pressure) OR Milrinone 0.25 to 0.5 mcg/kg/min IV (PDE-3 inhibitor, note: requires renal dose adjustment); VASODILATOR THERAPY (For hypertensive acute pulmonary edema): Nitroglycerin continuous IV infusion starting at 10-20 mcg/min titrated rapidly to reduce cardiac preload and afterload; MECHANICAL DECONGESTION (Extracorporeal Ultrafiltration / RRT): Slow Continuous Ultrafiltration (SCUF) or CVVH indicated for refractory diuretic resistance, persistent fluid overload, or progressive severe metabolic acidosis and hyperkalemia

⚠️ علائم خطر حیات (Red Flags):

  • !Withholding or discontinuing diuretic decongestion solely due to an asymptomatic mild-to-moderate rise in serum creatinine, leaving the patient with persistent high renal venous congestion which causes true progressive nephron loss
  • !Administering aggressive intravenous crystalloid hydration under the mistaken assumption that a rising creatinine in a congested heart failure patient represents prerenal dehydration
  • !Administering Milrinone in severe renal failure without adjusting the dose, precipitating severe systemic hypotension, intractable ventricular arrhythmias, and cardiac arrest

نفریت بینابینی حاد دارویی (AIN)

(Drug-Induced Acute Interstitial Nephritis (AIN))
ICD-10: N10مرجع: Brenner & Rector's The Kidney - Ch. 35

📋 نکات شرح حال (History Pearls):

  • •Medication exposure & latency: Acute or subacute decline in renal function occurring 7 to 14 days (range 1 day to several months) after initiation of a new culprit medication; high-risk classes: Antibiotics (penicillins, ampicillin, cephalosporins, ciprofloxacin, sulfamethoxazole-trimethoprim, rifampin), Proton Pump Inhibitors (omeprazole, pantoprazole, esomeprazole - classic indolent onset over months), NSAIDs (ibuprofen, naproxen, celecoxib - often accompanied by nephrotic-range proteinuria from concurrent minimal change disease), Antiepileptics, and Immune Checkpoint Inhibitors
  • •Classic hypersensitivity triad (Rarely complete): The classic triad of fever, maculopapular rash, and peripheral eosinophilia is present in LESS THAN 10-15% of confirmed biopsy cases; absence of systemic allergic features does NOT rule out AIN
  • •Constitutional symptoms: Low-grade fever, malaise, anorexia, dull bilateral flank or loin pain (secondary to stretching of the renal capsule from inflammatory interstitial edema), and mild arthralgias

🩺 معاینه فیزیکی (Physical Exam):

  • •Cutaneous hypersensitivity examination: Transient, non-pruritic or pruritic maculopapular, morbilliform, or erythematous rash on trunk and extremities (found in 20-40% of antibiotic-induced AIN, rarely in PPI-induced AIN)
  • •Renal & costovertebral tenderness: Bilateral costovertebral angle fullness and tenderness to percussion without signs of lower urinary tract infection or peritonitis
  • •Volume and blood pressure status: Blood pressure is frequently normal or only mildly elevated (unlike glomerulonephritis where severe hypertension is classic); absence of peripheral anasarca unless combined with NSAID-induced nephrotic syndrome

🧪 آزمایشگاه و تصویربرداری:

  • •Urinary Microscopic Sediment & Proteinuria: Active urine sediment: sterile pyuria (leukocyturia without bacteria), white blood cell casts (pathognomonic for interstitial inflammation), microscopic hematuria (seen in > 80%), and mild-to-moderate tubular proteinuria (< 1.0-1.5 g/24hr; except NSAID-induced AIN where proteinuria can be > 3.5 g/24hr); urinary eosinophils (Hansel stain) have poor diagnostic sensitivity/specificity and are no longer recommended as a definitive test
  • •Hematologic & Metabolic Parameters: Progressive elevation of serum creatinine and BUN; peripheral blood eosinophilia (absolute eosinophil count > 500/uL, present in ~30-40% of cases); mild hyperkalemia and renal tubular acidosis (Type 4 RTA) disproportionate to GFR reduction, reflecting inflammatory tubulointerstitial damage
  • •Definitive Gold Standard Diagnostic Renal Biopsy: Percutaneous renal biopsy demonstrating extensive diffuse interstitial edema with dense inflammatory cell infiltrate (predominantly CD4+ T lymphocytes, monocytes, macrophages, plasma cells, and eosinophils) and tubulitis (invasion of inflammatory cells into tubular basement membranes), with preservation of glomeruli and blood vessels

💊 دستورات بستری و درمانی (Generic INN):

  • ✓Diet/Activity: Moderate protein diet (1.0-1.2 g/kg/day); sodium restriction (2 g/day); bed rest; avoid all non-essential medications; strict documentation and entry of the culprit drug into patient allergy records to prevent future re-exposure
  • ✓Monitoring: Serial serum creatinine, BUN, and electrolytes every 48 hours; strict daily intake and output; daily physical examination for resolution of rash or systemic hypersensitivity; monitor for corticosteroid-induced hyperglycemia and hypertension
  • ✓IV Hydration: Maintain euvolemia with balanced crystalloids or 0.9% Normal Saline at maintenance rates if volume depleted; strictly avoid fluid overloading; avoid forced diuresis which does not accelerate interstitial inflammatory clearance
  • ✓Pharmacotherapy (Generic Only): IMMEDIATE WITHDRAWAL OF SUSPECTED OFFENDING DRUG (Cardinal First Step): Discontinue all newly started antibiotics, proton pump inhibitors (switch to generic Famotidine or H2-antagonists if acid suppression required), NSAIDs, and other potential culprits immediately; SYSTEMIC CORTICOSTEROID THERAPY (Initiate if serum creatinine fails to improve within 3 to 7 days of drug withdrawal, or immediately if severe renal failure / biopsy-confirmed AIN): Prednisone 1 mg/kg/day orally (maximum 60 mg/day) for 2 to 4 weeks (or intravenous Methylprednisolone 250 to 500 mg IV daily for 3 days followed by oral prednisone for severe acute presentations); once serum creatinine improves toward baseline, taper prednisone gradually over 4 to 6 weeks; GASTRIC PROTECTION & INFECTION PROPHYLAXIS: Famotidine 20 mg orally once daily; Sulfamethoxazole-Trimethoprim 800/160 mg orally three times weekly (or Atovaquone 1500 mg orally daily) if prolonged high-dose corticosteroid therapy; SECOND-LINE IMMUNOSUPPRESSION (For steroid-refractory or steroid-dependent AIN): Mycophenolate Mofetil 500 to 1000 mg orally twice daily for 2 to 3 months

⚠️ علائم خطر حیات (Red Flags):

  • !Delaying the initiation of systemic corticosteroids beyond 7 to 14 days in drug-induced AIN with unresolving kidney injury, leading to irreversible interstitial fibrosis and chronic end-stage kidney disease
  • !Re-challenging the patient with the offending medication or a related drug from the same chemical class, triggering hyperacute, catastrophic interstitial inflammation and anuric renal failure
  • !Ruling out acute interstitial nephritis solely because the patient lacks the classic triad of fever, rash, and eosinophilia, which is absent in over 85% of cases

گلومرولونفریت هلال‌دار پیشرونده سریع (RPGN و واسکولیت‌های وابسته به ANCA و Anti-GBM)

(Rapidly Progressive Crescentic Glomerulonephritis (RPGN / ANCA Vasculitis / Anti-GBM Disease))
ICD-10: N01.9مرجع: Brenner & Rector's The Kidney - Ch. 36

📋 نکات شرح حال (History Pearls):

  • •Hyperacute nephritic decline: Subacute or rapid deterioration in renal function (doubling of serum creatinine or > 50% GFR reduction over days to weeks) accompanied by gross smoky, tea-colored, or cola-colored hematuria, oliguria, and systemic constitutional toxicity
  • •Major etiologic categories (Immunopathologic Classification): Type I: Anti-Glomerular Basement Membrane (anti-GBM) antibody disease (Goodpasture syndrome; pulmonary-renal syndrome with pulmonary hemorrhage); Type II: Immune-complex mediated (lupus nephritis, post-infectious, IgA nephropathy, cryoglobulinemia); Type III: Pauci-immune necrotizing crescentic GN / ANCA-associated vasculitis (Granulomatosis with Polyangiitis [GPA / Wegener], Microscopic Polyangiitis [MPA], Eosinophilic GPA [Churg-Strauss])
  • •Pulmonary-Renal Syndrome & systemic vasculitis: Concomitant dyspnea, dry cough, hemoptysis, pleuritic chest pain (diffuse alveolar hemorrhage); constitutional prodrome: high fevers, migratory arthralgias, purpuric skin rash, chronic sinusitis/epistaxis, saddle-nose deformity, or peripheral neuropathy (mononeuritis multiplex)

🩺 معاینه فیزیکی (Physical Exam):

  • •Nephritic syndrome findings: New-onset or accelerating moderate-to-severe hypertension, mild-to-moderate periorbital and pretibial edema, oliguria, and dark smoky urine
  • •Systemic vasculitis stigmata: Palpable purpura (leukocytoclastic vasculitis) on lower extremities, livedo reticularis, digital ischemia/necrosis, nasal mucosal ulcerations, septal perforation, or episcleritis/scleritis
  • •Pulmonary auscultation: Bilateral inspiratory crackles and rhonchi; tachypnea, severe hypoxemia indicating pulmonary alveolar hemorrhage

🧪 آزمایشگاه و تصویربرداری:

  • •Active Nephritic Urine Sediment (Diagnostic Hallmark): Centrifuged urine sediment demonstrating dysmorphic red blood cells (> 70-80% acanthocytes, ring forms with blebs), red blood cell casts (pathognomonic for active glomerulonephritis), cellular debris, and sub-nephrotic to nephrotic proteinuria (typically 1.0-3.0 g/24hr)
  • •Stat Serologic & Immunologic Panel: Anti-GBM antibodies (positive in Goodpasture disease); Antineutrophil Cytoplasmic Antibodies (ANCA): c-ANCA / Anti-Proteinase 3 (PR3-ANCA, typical for GPA) and p-ANCA / Anti-Myeloperoxidase (MPO-ANCA, typical for MPA); Antinuclear Antibodies (ANA), double-stranded DNA (dsDNA); Serum complement levels (low C3/C4 in Type II immune complex GN; normal complement in Type I and Type III pauci-immune GN); Cryoglobulins
  • •Stat Percutaneous Renal Biopsy: Emergent diagnostic biopsy: light microscopy demonstrating extensive cellular crescents filling Bowman space in > 50% of glomeruli, fibrinoid necrosis of capillary tufts; Immunofluorescence: linear IgG/C3 along GBM (Type I anti-GBM), granular 'lumpy-bumpy' immune deposits (Type II), or negative/pauci-immune staining (Type III)

💊 دستورات بستری و درمانی (Generic INN):

  • ✓Diet/Activity: Strict sodium restriction (< 2 g/day); potassium restriction (< 40 mEq/day); bed rest; emergency transfer to a tertiary nephrology center equipped for immediate plasma exchange and emergency renal biopsy; prepare for emergent hemodialysis if anuric
  • ✓Monitoring: Intensive Care Unit admission; continuous cardiac telemetry, continuous pulse oximetry, arterial line blood pressure monitoring; strict hourly Foley urine output; serial serum creatinine, electrolytes, arterial blood gas, and complete blood count every 6 to 12 hours; serial chest radiographs to screen for alveolar hemorrhage
  • ✓IV Hydration: Cautious crystalloid administration; strict fluid restriction (insensible losses 500 mL/day plus urine output) to avoid precipitating pulmonary edema in an oliguric, nephritic patient; strictly avoid potassium-containing IV fluids
  • ✓Pharmacotherapy (Generic Only): HIGH-DOSE PULSE CORTICOSTEROIDS (Initiate immediately upon clinical suspicion): Methylprednisolone 500 to 1000 mg IV infusion daily for 3 consecutive days, followed by oral Prednisone 1 mg/kg/day (maximum 60-80 mg/day) with a structured taper; PLUS CYTOTOXIC IMMUNOSUPPRESSION (First-Line): Cyclophosphamide 15 mg/kg IV pulse every 2 to 3 weeks (adjusted for age and renal function) OR Cyclophosphamide 1.5 to 2.0 mg/kg/day orally PLUS Mesna 20-40% of cyclophosphamide dose to prevent hemorrhagic cystitis; ALTERNATIVE BIOLOGIC INDUCTION (For ANCA Vasculitis): Rituximab 375 mg/m2 IV weekly for 4 weeks (or 1000 mg IV on days 0 and 14); THERAPEUTIC PLASMA EXCHANGE (PLEX / Plasmapheresis): MANDATORY for Anti-GBM disease (daily 4-liter 1.0 plasma volume exchanges with 5% albumin replacement for 14 days or until anti-GBM antibodies are undetectable) AND for severe ANCA vasculitis with concurrent diffuse alveolar hemorrhage or severe AKI (creatinine > 5.7 mg/dL); PNEUMOCYSTIS & GASTRIC PROPHYLAXIS: Sulfamethoxazole-Trimethoprim 800/160 mg orally three times weekly (or Atovaquone 1500 mg orally daily) PLUS Pantoprazole 40 mg orally once daily

⚠️ علائم خطر حیات (Red Flags):

  • !Delaying pulse Methylprednisolone or urgent renal biopsy while awaiting outpatient serologic results, allowing reversible cellular crescents to organize into irreversible fibrous crescents and permanent cortical sclerosis
  • !Failing to immediately recognize and treat alveolar hemorrhage (hemoptysis with bilateral infiltrates), resulting in asphyxiation and death within hours
  • !Withholding therapeutic plasma exchange in Anti-GBM antibody disease, depriving the patient of the only proven modality to clear circulating pathogenic antibodies before permanent end-stage renal failure occurs

سندرم نفروتیک حاد با آنازارکای شدید و خطر ترومبوآمبولی

(Acute Nephrotic Syndrome with Severe Anasarca and Thromboembolic Risk)
ICD-10: N04.9مرجع: Brenner & Rector's The Kidney - Ch. 34

📋 نکات شرح حال (History Pearls):

  • •Cardinal nephrotic tetrad: Heavy proteinuria (> 3.5 g/24hr or urine protein-to-creatinine ratio > 3.0-3.5 g/g), profound hypoalbuminemia (serum albumin < 2.5-3.0 g/dL), generalized severe peripheral and body anasarca, and severe hyperlipidemia (hypercholesterolemia, elevated LDL, lipiduria)
  • •Rapid fluid accumulation: Rapid onset of periorbital morning puffiness, progressive tight swelling of both lower extremities extending to thighs, scrotal or vulvar edema, ascites, pleural effusions causing dyspnea, and rapid weight gain (> 10-15 kg over weeks)
  • •Hypercoagulable and infectious vulnerability: History of deep vein thrombosis, pulmonary embolism, or renal vein thrombosis (manifesting as sudden flank pain, hematuria, and acute decline in GFR); heightened susceptibility to encapsulated bacterial infections (Streptococcus pneumoniae cellulitis, peritonitis) due to urinary loss of immunoglobulins and complement factor B

🩺 معاینه فیزیکی (Physical Exam):

  • •Severe generalized anasarca: Bilateral 4+ pitting lower extremity edema extending up to the groin, massive dependent presacral edema, scrotal or labial ballooning; tense ascites with shifting dullness; dullness to percussion and decreased breath sounds at lung bases (bilateral transudative pleural effusions)
  • •Periorbital & facial edema: Prominent periorbital edema and facial puffiness, characteristically most severe upon awakening in the morning
  • •Integumentary & vascular examination: Skin pallor, fragile shiny edematous skin with striations; evaluate for signs of superficial thrombophlebitis, deep vein thrombosis, or localized warm tender erythema of cellulitis

🧪 آزمایشگاه و تصویربرداری:

  • •Urinary Diagnostics & Lipiduria: 24-hour urine collection for total protein (proteinuria > 3.5 g/day) or spot urine protein-to-creatinine ratio (UPCR > 3.5 g/g); microscopic examination of urine sediment demonstrating oval fat bodies (degenerated tubular cells loaded with lipid droplets) and fatty casts displaying the classic 'Maltese cross' pattern under polarized light; microscopic hematuria may be present
  • •Serum Chemistry & Lipid Profile: Marked hypoalbuminemia (serum albumin frequently 1.5-2.2 g/dL); severe hyperlipidemia (total serum cholesterol > 300-500 mg/dL, elevated triglycerides, low HDL/LDL ratio); elevated BUN and serum creatinine in secondary renal impairment; normal or low serum calcium (falsely low due to hypoalbuminemia; check ionized calcium)
  • •Etiologic Serologic Workup & Biopsy: Anti-PLA2R antibodies (positive in 70-80% of primary Membranous Nephropathy); ANA, anti-dsDNA, complement C3/C4 (Lupus Nephritis); serum protein electrophoresis and serum free light chains (AL Amyloidosis / Multiple Myeloma); viral serologies (Hepatitis B, Hepatitis C, HIV); Percutaneous Renal Biopsy to establish definitive histopathology (Minimal Change Disease, Focal Segmental Glomerulosclerosis, Membranous Nephropathy, Membranoproliferative GN)

💊 دستورات بستری و درمانی (Generic INN):

  • ✓Diet/Activity: Strict dietary sodium restriction to 1.5 to 2.0 g/day (essential to mobilize edema); moderate protein diet (0.8 to 1.0 g/kg/day; high-protein diets do NOT raise serum albumin and worsen glomerular hyperfiltration and proteinuria); low-saturated fat and low-cholesterol diet; bed rest with periodic leg elevation; avoid prolonged bed immobilization to reduce venous thromboembolism risk
  • ✓Monitoring: Daily morning body weight on the same calibrated scale (target weight loss 0.5-1.0 kg/day); strict fluid intake and output monitoring; blood pressure monitoring every 4-6 hours; serial serum creatinine, BUN, electrolytes, and serum albumin every 48 hours; screen for symptoms of deep vein thrombosis or pulmonary embolism
  • ✓IV Hydration: Avoid routine IV crystalloids; ALBUMIN-LOOP DIURETIC CO-INFUSION (For severe refractory anasarca or diuretic resistance in profound hypoalbuminemia < 2.0 g/dL): Administer 20% or 25% Albumin 100 mL (20 to 25 grams) IV infusion over 30 to 60 minutes, followed immediately by Furosemide 80 to 160 mg IV push (albumin binds loop diuretic, expands intravascular oncotic volume, and delivers diuretic to the tubular lumen to overcome resistance)
  • ✓Pharmacotherapy (Generic Only): FIRST-LINE DIURETIC REGIMEN: Furosemide 40 to 80 mg IV twice daily (or Bumetanide 1 to 2 mg IV twice daily); SEQUENTIAL NEPHRON BLOCKADE: Add Metolazone 2.5 to 5.0 mg orally once daily (or Spironolactone 25 to 50 mg orally once daily if potassium permits) administered 30 minutes prior to loop diuretic; ANTICOAGULATION PROPHYLAXIS (Mandatory for high-risk patients: serum albumin < 2.0-2.5 g/dL with Membranous Nephropathy or additional thrombotic risk factors): Enoxaparin 40 mg subcutaneously once daily (or Heparin 5000 units subcutaneously every 8-12 hours; or therapeutic oral anticoagulation with generic Apixaban or Warfarin if confirmed thrombosis); RENIN-ANGIOTENSIN SYSTEM BLOCKADE (Once acute edema improves and hemodynamically stable): Lisinopril 5 to 10 mg orally once daily OR Losartan 25 to 50 mg orally once daily (reduces intraglomerular capillary pressure and decreases proteinuria); HYPERLIPIDEMIA MANAGEMENT: Atorvastatin 20 to 40 mg orally once daily; EMPIRIC IMMUNOSUPPRESSION (Minimal Change Disease / First Episode): Prednisone 1 mg/kg/day orally (maximum 80 mg/day) as a single morning dose for 8 to 12 weeks once biopsy confirms MCD

⚠️ علائم خطر حیات (Red Flags):

  • !Overly aggressive, massive diuresis in a severely hypoalbuminemic patient with depleted intravascular volume, triggering acute hypovolemic shock, prerenal acute kidney injury, and vascular thrombosis
  • !Failing to prescribe prophylactic anticoagulation in high-risk membranous nephropathy with serum albumin < 2.0 g/dL, resulting in fatal pulmonary embolism or renal vein thrombosis
  • !Prescribing high-protein diets (> 1.5-2.0 g/kg/day) to 'replace urinary protein losses', which accelerates intraglomerular hypertension, worsens proteinuria, and hastens renal fibrosis

رابدومیولیز و نفروپاتی پیگمانی همراه با دیورز قلیایی

(Rhabdomyolysis and Pigment Nephropathy with Forced Alkaline Diuresis)
ICD-10: M62.82مرجع: Brenner & Rector's The Kidney - Ch. 31

📋 نکات شرح حال (History Pearls):

  • •Massive skeletal muscle necrosis & triad: The classic triad of muscle pain (severe myalgia), generalized muscle weakness, and dark tea-colored / cola-colored urine; however, this triad is present in less than 10% of patients at onset
  • •Etiologic triggers & mechanisms: Traumatic crush injury, prolonged immobilization / 'found down' on hard floor (elderly fall, alcohol or drug intoxication, stroke, coma), extreme unaccustomed exertion (marathon, military recruit training, crossfit), grand mal status epilepticus, hyperthermia (heat stroke, neuroleptic malignant syndrome, malignant hyperthermia), severe hypothermia, arterial occlusion / compartment syndrome reperfusion, medications (statins combined with gemfibrozil, antiretrovirals, colchicine), or severe electrolyte derangements (hypokalemia, hypophosphatemia)
  • •Progression to pigment-induced acute kidney injury: Myoglobin-mediated acute tubular necrosis resulting from renal vasoconstriction (endothelin excess, nitric oxide scavenging), direct oxidant tubular cytotoxicity, and intratubular cast precipitation (Tamm-Horsfall protein polymerizing with ferrihemate in acidic urine)

🩺 معاینه فیزیکی (Physical Exam):

  • •Muscular palpation & compartment tension: Marked muscle tenderness, swelling, edema, and woody brawny induration, most commonly involving calves, thighs, gluteal muscles, or back; examine extremities vigilantly for tight, tense compartments and excruciating pain on passive stretch indicating acute compartment syndrome
  • •Cutaneous pressure signs: Skin erythema, blisters, bullae, pressure necrosis over dependent pressure points in immobilized patients
  • •Urine gross appearance: Gross dark reddish-brown, tea-colored, or cola-colored urine lacking visible blood clots

🧪 آزمایشگاه و تصویربرداری:

  • •Serum Creatine Kinase (CK - Cardinal Biomarker): Serum CK elevated > 5 times the upper limit of normal (typically > 5,000-10,000 U/L; levels frequently exceed 50,000 to 100,000+ U/L in severe cases; CK peaks at 24 to 72 hours post-injury; risk of AKI rises steeply when CK > 15,000-20,000 U/L)
  • •Urine Dipstick vs Centrifuged Sediment Discrepancy (Pathognomonic): Urine dipstick strongly positive for 'blood' (orthotolidine reagent detects heme moiety of both hemoglobin and myoglobin) BUT centrifuged microscopic sediment reveals ZERO or very few red blood cells; dipstick (+) and microscopy (-) is the diagnostic hallmark of myoglobinuria; clear centrifuged plasma differentiates myoglobinuria from hemoglobinuria (where plasma is pink)
  • •Electrolyte Cascade & Metabolic Derangements: Hyperacute severe hyperkalemia (massive release from necrotic myocytes), marked hyperphosphatemia, early hypocalcemia (deposition of calcium phosphate in damaged muscle tissue; DO NOT treat early hypocalcemia unless symptomatic), high anion gap metabolic acidosis, elevated serum uric acid (> 10-15 mg/dL), and severe prerenal or intrinsic AKI

💊 دستورات بستری و درمانی (Generic INN):

  • ✓Diet/Activity: Strict NPO initially; absolute bed rest; emergency surgical evaluation if limb compartment syndrome suspected (urgent decompressive fasciotomy); avoid physical exertion
  • ✓Monitoring: Intensive Care Unit admission; continuous ECG telemetry; continuous non-invasive or arterial blood pressure monitoring; Foley catheter with temperature sensor for strict hourly urine output measurement (target urine output strictly 200 to 300 mL/hr until CK drops < 5,000 U/L); serial serum CK, potassium, calcium, phosphate, BUN, and creatinine every 6 hours; urine pH monitoring at bedside every 2 hours
  • ✓IV Hydration: AGGRESSIVE EARLY INTRAVENOUS VOLUME EXPANSION (The Single Most Effective Intervention to Prevent Pigment AKI): Infuse balanced crystalloids (Plasma-Lyte or 0.9% Normal Saline) at 500 to 1000 mL/hr immediately upon recognition; adjust infusion rate to maintain high urine flow rate of 200 to 300 mL/hr (typically requires 6 to 12 Liters of crystalloids in the first 24 hours); once volume status is replete and high urine output established, titrate fluids to avoid fluid overload
  • ✓Pharmacotherapy (Generic Only): URINARY ALKALINIZATION PROTOCOL (Indicated ONLY if patient is euvolemic, producing urine, urine pH < 6.5, and serum calcium is normal): Add Sodium Bicarbonate 100 to 150 mEq to 1000 mL 5% Dextrose in Water (D5W) infused at 200 to 250 mL/hr to target urine pH >= 6.5 to 7.0 (alkaline pH prevents precipitation of myoglobin with Tamm-Horsfall protein and reduces redox generation of free radicals; STOP bicarbonate if arterial pH > 7.50, serum bicarbonate > 30 mEq/L, or hypocalcemia develops); MANNITOL CONTROVERSY: Mannitol 20% 0.5 g/kg IV over 30 minutes may be considered ONLY if adequate volume resuscitation fails to achieve target urine output > 200 mL/hr (discontinue if diuresis is not established to prevent hyperosmolar overload and anuric tubular injury); HYPERKALEMIA MANAGEMENT: Calcium Gluconate 10% 10-20 mL IV for ECG stabilization, Regular Insulin 10 units IV with 50 mL 50% Dextrose; HYPOCALCEMIA WARNING: Strictly avoid routine calcium repletion during the acute phase unless life-threatening tetany, seizures, or severe hyperkalemic cardiotoxicity occurs, as administered calcium deposits into injured myocytes and exacerbates severe rebound hypercalcemia during the diuretic recovery phase; RENAL REPLACEMENT THERAPY: Intermittent Hemodialysis or CRRT indicated for refractory hyperkalemia, severe acidosis, or volume overload in oliguric/anuric AKI

⚠️ علائم خطر حیات (Red Flags):

  • !Routinely administering intravenous Calcium to correct asymptomatic early hypocalcemia, causing massive metastatic soft tissue and muscle calcification, and catastrophic severe hypercalcemia during the recovery phase
  • !Delaying aggressive intravenous crystalloid volume resuscitation while awaiting laboratory confirmation of CK, allowing irreversible pigment nephropathy and acute tubular necrosis to establish
  • !Administering sodium bicarbonate for urine alkalinization in an un-resuscitated hypocalcemic or alkalemic patient, precipitating severe tetany, seizures, and metabolic decompensation

کلسیفیلاکسی (آرتریولوپاتی کلسیفیک اورمیک) در بیماری پیشرفته مزمن کلیه

(Calciphylaxis (Calcific Uremic Arteriolopathy) in Advanced Chronic Kidney Disease)
ICD-10: E83.59مرجع: Brenner & Rector's The Kidney - Ch. 53

📋 نکات شرح حال (History Pearls):

  • •Life-threatening vascular calcification syndrome: Severe, agonizing, unrelenting cutaneous pain and ischemic necrosis occurring in patients with end-stage kidney disease on maintenance hemodialysis (or peritoneal dialysis), kidney transplant recipients, or advanced chronic kidney disease
  • •Lesion evolution: Early stage: extremely painful, tender subcutaneous violaceous or purpuric plaques, mottled livedo reticularis, or firm indurated nodules in areas of high adipose tissue (abdomen, thighs, buttocks, breasts; proximal lesions have worse prognosis than distal extremities); Late stage: rapid ischemic ulceration with thick, adherent, black, leathery, necrotic eschars and gangrene
  • •High-risk medication & metabolic triggers: Warfarin exposure (potent inhibitor of matrix Gla protein, a key vascular calcification inhibitor); calcium-based phosphate binders; active vitamin D analogs; severe secondary hyperparathyroidism; hyperphosphatemia; female sex, obesity, diabetes mellitus, and systemic hypoalbuminemia

🩺 معاینه فیزیکی (Physical Exam):

  • •Exquisite cutaneous tenderness: Extreme, disproportionate, burning or lancinating pain upon light touch of the affected skin and subcutaneous tissue; lesions are characteristically bilateral and symmetrical
  • •Cutaneous morphology: Violaceous, retiform purpura evolving into indurated 'woody' subcutaneous plaques with stellate borders, progressing to deep, punched-out, angulated ulcers covered by dry, blackened, necrotic eschars; secondary bacterial superinfection is frequent
  • •Peripheral pulses: Distal arterial pulses (dorsalis pedis, posterior tibial) are typically INTACT and palpable, because calciphylaxis is a microvascular obliterative arteriolar disease of subcutaneous small vessels (50-200 mcm diameter), not a macrovascular large-artery occlusive disease

🧪 آزمایشگاه و تصویربرداری:

  • •Mineral Bone Disorder Laboratory Profile: Markedly elevated serum calcium-phosphate product (Ca x P > 55-70 mg2/dL2); severe hyperphosphatemia (> 5.5-7.0 mg/dL); serum intact parathyroid hormone (PTH) frequently markedly elevated (> 500-1000 pg/mL in severe secondary hyperparathyroidism) OR paradoxically very low (< 100 pg/mL in adynamic bone disease); profound hypoalbuminemia (< 3.0 g/dL)
  • •Skin Punch Biopsy (Proceed with Extreme Caution): Deep punch or incisional biopsy reaching subcutaneous adipose tissue demonstrating medial calcification of small-to-medium arterioles (Von Kossa or Alizarin red stain), intimal fibroblastic hyperplasia, microvascular luminal thrombosis, and ischemic subcutaneous fat necrosis; NOTE: Biopsy carries a high risk of non-healing ulceration, hemorrhage, and fatal secondary sepsis, so clinical diagnosis is often preferred
  • •Plain Radiography / Mammography of Soft Tissues: High-resolution radiographs of the thighs, abdomen, or soft tissues demonstrating diffuse, delicate, net-like 'pipe-stem' vascular calcification of subcutaneous arterioles

💊 دستورات بستری و درمانی (Generic INN):

  • ✓Diet/Activity: Strict low-phosphate diet (< 800 mg/day); aggressive wound protection: pressure-relieving air mattress; gentle mobilization; strict multi-disciplinary approach with wound care, nephrology, dermatology, and palliative pain management
  • ✓Monitoring: Intensive inpatient monitoring; daily photographic mapping of ulcer borders and depth; daily pain scoring; serial serum calcium, phosphate, and intact PTH every 48 hours; vigilantly monitor for signs of systemic sepsis and bloodstream infection from ulcerated lesions (the leading cause of death in calciphylaxis)
  • ✓IV Hydration: Maintain euvolemia; OPTIMIZE DIALYSIS REGIMEN: Intensify hemodialysis frequency and duration to 5 to 6 sessions per week (or daily nocturnal hemodialysis) using low-calcium dialysate bath (1.5 to 2.0 mEq/L Ca) to maximize phosphate clearance and achieve negative calcium balance
  • ✓Pharmacotherapy (Generic Only): FIRST-LINE SPECIFIC THERAPY (Antioxidant & Calcium Chelator): Sodium Thiosulfate 25 grams (100 mL of 25% solution) IV infused during the last 30 to 60 minutes of each hemodialysis session 3 times weekly (or 12.5 g IV for body weight < 60 kg); continue for 3 to 6 months until complete ulcer healing; monitor for high anion gap metabolic acidosis and fluid overload; DISCONTINUE OFFENDING AGENTS (Immediate Action): IMMEDIATELY STOP Warfarin (switch to alternative anticoagulation: generic Enoxaparin or Apixaban if indicated), STOP all calcium-based phosphate binders (calcium carbonate, calcium acetate), STOP all active Vitamin D analogs (calcitriol, paricalcitol); CONTROL HYPERPHOSPHATEMIA: Non-calcium, non-aluminum phosphate binders: Sevelamer Carbonate 800 to 1600 mg orally three times daily with meals OR Lanthanum Carbonate 500 to 1000 mg orally three times daily (target serum phosphate < 4.5-5.5 mg/dL); CONTROL HYPERPARATHYROIDISM: Calcimimetic therapy: Cinacalcet 30 to 60 mg orally once daily to suppress PTH without increasing serum calcium or phosphate; MULTIMODAL WOUND MANAGEMENT & ANALGESIA: Surgical debridement must be ultra-conservative (avoid aggressive surgical excision which enlarges necrotic defects); enzymatic debridement with collagenase; silver-impregnated or honey-based non-adherent dressings; high-dose opioid analgesia (Fentanyl or Hydromorphone titrated to effect)

⚠️ علائم خطر حیات (Red Flags):

  • !Continuing Warfarin therapy in a hemodialysis patient presenting with painful violaceous skin lesions, directly accelerating microvascular calcification and fatal systemic tissue necrosis
  • !Performing wide, aggressive radical surgical debridement or skin grafting on active calciphylaxis ulcers, creating massive non-healing surgical wounds that rapidly succumb to fatal polymicrobial sepsis
  • !Administering calcium-containing phosphate binders or active vitamin D analogs in a patient with active calciphylaxis, driving metastatic arteriolar calcification

هیپوکالمی شدید با فلج شل بالارونده و آریتمی‌های بطنی

(Severe Hypokalemia with Ascending Flaccid Paralysis and Ventricular Arrhythmias)
ICD-10: E87.6مرجع: Brenner & Rector's The Kidney - Ch. 17

📋 نکات شرح حال (History Pearls):

  • •Critical electrolyte depletion threshold: Serum potassium < 2.5 mEq/L (often < 2.0 mEq/L), representing a profound total body potassium deficit of 400 to 800+ mEq (every 1.0 mEq/L drop below 4.0 mEq/L represents ~200-400 mEq total body deficit)
  • •Precipitating mechanisms: Gastrointestinal losses (protracted vomiting, nasogastric suction, severe secretory diarrhea, VIPoma, laxative abuse); Renal losses (loop and thiazide diuretics, mineralocorticoid excess / primary aldosteronism, Cushing syndrome, renal tubular acidosis types 1 and 2, Bartter and Gitelman syndromes, amphotericin B nephrotoxicity); Acute intracellular shift (insulin excess, beta-2 adrenergic agonists, refeeding syndrome, thyrotoxic hypokalemic periodic paralysis)
  • •Neuromuscular & systemic symptoms: Generalized muscle weakness progressing rapidly to ascending symmetric flaccid paralysis (mimicking Guillain-Barre syndrome), severe hypoventilation / respiratory failure from diaphragmatic paralysis, muscle cramps, severe rhabdomyolysis (hypokalemia induces skeletal muscle arteriolar vasoconstriction and ischemia), constipation, and paralytic ileus

🩺 معاینه فیزیکی (Physical Exam):

  • •Neuromuscular examination: Symmetric flaccid quadriparesis predominantly affecting proximal lower extremities, generalized hyporeflexia or complete areflexia; cranial nerves and sensory examination are characteristically spared
  • •Respiratory compromise assessment: Shallow respirations, tachypnea followed by bradypnea, paradoxical abdominal breathing (diaphragmatic exhaustion), and hypoxemia
  • •Abdominal & cardiovascular examination: Distended, silent abdomen with absent bowel sounds (paralytic ileus); resting tachycardia, irregular pulse, orthostatic hypotension, and systolic ejection flow murmur

🧪 آزمایشگاه و تصویربرداری:

  • •12-Lead Electrocardiographic Derangements: Characteristic sequential progression: flattening and inversion of T waves, prominent U waves (appearing after the T wave in precordial leads V2-V4), ST-segment depression (> 0.5 mm), prolongation of the apparent QT interval (actually QU interval); progression to lethal arrhythmias: frequent premature ventricular contractions (PVCs), junctional tachycardias, atrial fibrillation, torsades de pointes, ventricular tachycardia, and ventricular fibrillation (especially with concurrent digitalis therapy)
  • •Laboratory Electrolyte & Acid-Base Panel: Serum potassium confirmation; stat serum magnesium (MANDATORY: Hypomagnesemia impairs Na/K-ATPase and opens renal ROMK channels, causing massive renal potassium wasting; hypokalemia is 100% REFRACTORY to repletion until hypomagnesemia is corrected!); arterial blood gas: metabolic alkalosis (vomiting, diuretics, hyperaldosteronism) versus metabolic acidosis (diarrhea, RTA); serum CK (marked elevation in rhabdomyolysis)
  • •Urinary Potassium Excretion Metrics: Spot urine potassium (< 15-20 mEq/L indicates extrarenal loss or shift; > 20 mEq/L indicates inappropriate renal wasting); calculate Transtubular Potassium Gradient (TTKG > 7 indicates active aldosterone-driven renal wasting)

💊 دستورات بستری و درمانی (Generic INN):

  • ✓Diet/Activity: Strict NPO during acute paralysis, ileus, or cardiac arrhythmia; strict bed rest with continuous 12-lead cardiac telemetry in an Intensive Care Unit; immediate elective endotracheal intubation for impending respiratory arrest or diaphragmatic paralysis; high-potassium diet (rich in fruits, vegetables) once patient stabilizes and tolerates oral intake
  • ✓Monitoring: Continuous cardiac rhythm telemetry; cycling automated blood pressure every 15 minutes during rapid IV repletion; continuous pulse oximetry; Foley catheter for hourly urine output; repeat serum potassium, magnesium, and blood gas every 1 to 2 hours during active intravenous repletion until K+ > 3.0 mEq/L, then every 4 to 6 hours
  • ✓IV Hydration: STRICTLY AVOID DEXTROSE-CONTAINING IV SOLUTIONS (5% Dextrose stimulates endogenous insulin secretion, which drives potassium intracellularly and paradoxically precipitates lethal worsening of hypokalemia); infuse 0.9% Normal Saline at 100-150 mL/hr as the carrier vehicle
  • ✓Pharmacotherapy (Generic Only): RAPID INTRAVENOUS REPLACEMENT PROTOCOL (For severe paralysis, arrhythmia, or K+ < 2.0 mEq/L): Potassium Chloride 20 to 40 mEq/hr IV administered via central venous access (central line preferred due to peripheral vein sclerosis and burning pain; peripheral infusion rate should NOT exceed 10-20 mEq/hr; maximum central line rate 40 mEq/hr under continuous cardiac telemetry); TARGET: Raise serum potassium safely to > 3.0-3.5 mEq/L; MANDATORY MAGNESIUM REPLETION (Co-Administer Concurrently): Magnesium Sulfate 2.0 to 4.0 grams (16 to 32 mEq) IV infusion over 30 to 60 minutes, followed by 1-2 grams every 4 hours until serum magnesium > 2.0-2.4 mg/dL (hypokalemia cannot correct without magnesium); ORAL POTASSIUM REPLACEMENT (Transition as soon as safe and GI tract functional): Potassium Chloride 40 to 60 mEq orally every 4 to 6 hours (oral route is significantly safer and achieves more rapid total body expansion without vein irritation); POTASSIUM-SPARING DIURETICS (For chronic renal potassium wasting / Gitelman / Bartter / hyperaldosteronism): Spironolactone 25 to 100 mg orally daily OR Amiloride 5 to 10 mg orally daily; WITHHOLD DIGITALIS: Immediately discontinue or withhold digoxin (hypokalemia dramatically potentiates digitalis-induced fatal ventricular arrhythmias)

⚠️ علائم خطر حیات (Red Flags):

  • !Administering Potassium Chloride in 5% Dextrose solutions, stimulating endogenous insulin release which shifts potassium into cells and precipitates fatal cardiac arrest
  • !Attempting to correct severe hypokalemia without checking and aggressively repleting concurrent hypomagnesemia, leading to complete refractory potassium wasting and persistent arrhythmias
  • !Infusing Potassium Chloride at rates > 20 mEq/hr via a peripheral vein or > 40 mEq/hr via a central vein without telemetry, causing accidental hyperkalemic cardiac asystole

بحران حاد هیپرکلسمی و هیپرکلسمی مرتبط با بدخیمی

(Acute Hypercalcemic Crisis and Malignancy-Associated Hypercalcemia)
ICD-10: E83.52مرجع: Brenner & Rector's The Kidney - Ch. 18

📋 نکات شرح حال (History Pearls):

  • •Severe life-threatening calcium elevation: Total serum calcium > 14.0 mg/dL (3.5 mmol/L) or ionized calcium > 3.5 mg/dL (1.75 mmol/L), representing a medical emergency requiring rapid intervention
  • •Etiologic profile (> 90% caused by two conditions): Malignancy-associated hypercalcemia (humoral hypercalcemia of malignancy via Parathyroid Hormone-related Protein [PTHrP] in squamous cell lung/head/neck cancers; osteolytic bone metastases in breast cancer, multiple myeloma, lymphoma); Primary Hyperparathyroidism (parathyroid adenoma); Granulomatous disorders (sarcoidosis, tuberculosis with 1-alpha-hydroxylase calcitriol synthesis); severe vitamin D intoxication; immobilization
  • •Classic multi-organ symptom complex ('Bones, Stones, Groans, and Psychiatric Moans'): Profound anorexia, nausea, intractable vomiting, severe dehydration, constipation, obstipation, pancreatitis; polyuria and polydipsia (calcium-induced nephrogenic diabetes insipidus); severe lethargy, confusion, delirium, stupor, and hypercalcemic coma

🩺 معاینه فیزیکی (Physical Exam):

  • •Severe dehydration & hypovolemia: Markedly decreased skin turgor, parched dry tongue, sunken eyeballs, orthostatic hypotension, resting tachycardia, and flat neck veins resulting from severe calcium-mediated natriuresis and vomiting
  • •Neurological depression: Muscle hypotonia, generalized hyporeflexia, cognitive slowing, disorientation, stupor, or coma
  • •Abdominal & ocular examination: Diffuse abdominal tenderness without peritonitis (exclude hypercalcemic acute pancreatitis); Band keratopathy (calcium deposition in the corneal limbus visible on penlight or slit-lamp exam)

🧪 آزمایشگاه و تصویربرداری:

  • •Serum Calcium & Corrected Formula: Stat total serum calcium and ionized calcium; Corrected Calcium (mg/dL) = Measured Total Calcium + 0.8 x (4.0 - Serum Albumin in g/dL); hypercalcemic crisis typically manifests at corrected calcium > 14.0 mg/dL
  • •12-Lead Electrocardiographic Changes: Marked shortening of the QT interval (shortened ST segment with early T-wave take-off); PR interval prolongation, QRS widening; late severe changes: bradyarrhythmias, heart block, Osborn J waves, and ventricular dysrhythmias
  • •Diagnostic Endocrine & Malignancy Panel: Intact Parathyroid Hormone (PTH - suppressed in malignancy, elevated or inappropriately normal in primary hyperparathyroidism); Parathyroid Hormone-related Protein (PTHrP - elevated in humoral malignancy); 1,25-dihydroxyvitamin D (Calcitriol - elevated in lymphoma and granulomatous disease); 25-hydroxyvitamin D; Serum and Urine Protein Electrophoresis / Free Light Chains (Multiple Myeloma); BUN, creatinine, phosphorus, and alkaline phosphatase

💊 دستورات بستری و درمانی (Generic INN):

  • ✓Diet/Activity: Strict NPO during crisis; strict bed rest with seizure and fall precautions; passive mobilization once hydrated to prevent further immobilization-induced bone resorption; strictly avoid dietary calcium and vitamin D
  • ✓Monitoring: Intensive Care Unit admission; continuous cardiac rhythm telemetry; arterial line blood pressure monitoring; Foley catheter with hourly urine output measurement; serial ionized calcium, total calcium, sodium, potassium, and magnesium every 4 to 6 hours; continuous monitoring for fluid overload during massive crystalloid hydration
  • ✓IV Hydration: AGGRESSIVE INTRAVENOUS VOLUME EXPANSION (The Essential Immediate First Step): Infuse 0.9% Normal Saline at 200 to 500 mL/hr IV (initial 1000-2000 mL bolus over 2 hours) to restore intravascular volume, enhance glomerular filtration, and promote urinary calcium excretion via proximal tubular sodium-calcium co-transport; target urine output 100-150 mL/hr; maintain euvolemia with 2 to 4 Liters of Normal Saline daily; avoid fluid overload in heart failure
  • ✓Pharmacotherapy (Generic Only): IMMEDIATE SHORT-ACTING CALCIUM-LOWERING AGENT: Calcitonin (salmon calcitonin) 4 to 8 units/kg subcutaneously or intramuscularly every 12 hours (rapid onset within 2-4 hours, lowers calcium by 1-2 mg/dL by inhibiting osteoclasts and promoting kaliuresis; tachyphylaxis develops after 48 hours due to receptor downregulation; serves as a temporary bridge to bisphosphonates); POTENT INTRAVENOUS BISPHOSPHONATES (First-Line Definitive Therapy for Malignancy Hypercalcemia): Zoledronic acid 4 mg IV infusion diluted in 100 mL 0.9% Normal Saline infused over at least 15 minutes (dose reduced to 3.5 mg if moderate CKD; hold if severe renal failure) OR Pamidronate 60 to 90 mg IV infusion over 2 to 4 hours; onset 48 to 72 hours, nadir at 4 to 7 days, effect lasts 2 to 4 weeks; MONOCLONAL RANK-LIGAND INHIBITOR (Preferred in Severe Renal Impairment / Bisphosphonate Refractory): Denosumab 120 mg subcutaneously once weekly for 3 weeks then monthly (does NOT require renal dose adjustment; potent inhibitor of osteoclast maturation); SYSTEMIC CORTICOSTEROIDS (For Lymphoma, Multiple Myeloma, Sarcoidosis): Hydrocortisone 100 mg IV every 8 hours OR Prednisone 40 to 60 mg orally daily for 3 to 5 days (inhibits 1-alpha-hydroxylase and reduces intestinal calcium absorption); LOOP DIURETIC RESTRICTION: Furosemide 20 to 40 mg IV is indicated ONLY AFTER full volume rehydration has been achieved, and solely to prevent volume overload (routine forced saline-furosemide diuresis is contraindicated due to severe electrolyte collapse); EMERGENCY HEMODIALYSIS: Low-calcium or zero-calcium bath hemodialysis indicated for hypercalcemic crisis with anuric renal failure or refractory pulmonary edema

⚠️ علائم خطر حیات (Red Flags):

  • !Administering intravenous Furosemide before the patient is completely volume-repleted with 0.9% Normal Saline, worsening severe intravascular dehydration and driving calcium levels higher
  • !Administering intravenous Zoledronic acid as a rapid bolus (< 15 minutes), precipitating acute tubular necrosis and acute renal failure
  • !Relying on Calcitonin alone without concurrent Bisphosphonate or Denosumab therapy, resulting in severe rebound hypercalcemia within 48 hours due to tachyphylaxis

اسیدوز متابولیک حاد شدید با شکاف آنیونی بالا و کمبود بی‌کربنات

(Severe Acute Metabolic Acidosis with High Anion Gap and Bicarbonate Deficit)
ICD-10: E87.2مرجع: Brenner & Rector's The Kidney - Ch. 19

📋 نکات شرح حال (History Pearls):

  • •Severe life-threatening acidemia: Arterial pH < 7.10-7.15 and serum bicarbonate < 10-12 mEq/L, threatening severe cardiovascular collapse, refractory vasoplegia, myocardial depression, and fatal ventricular arrhythmias
  • •Etiologic triage by Serum Anion Gap (AG = Na - [Cl + HCO3]): High Anion Gap Metabolic Acidosis (HAGMA > 12 mEq/L; mnemonic GOLD MARK): Glycols (ethylene glycol, propylene glycol), Oxoproline (chronic acetaminophen misuse), L-Lactate (septic, cardiogenic, or hypovolemic shock), D-Lactate (short bowel syndrome), Methanol (toxic alcohol), Aspirin (salicylates), Renal failure (uremic acidosis), Ketoacidosis (diabetic, alcoholic, starvation); Normal Anion Gap Metabolic Acidosis (NAGMA / hyperchloremic; AG <= 12 mEq/L): severe diarrhea, renal tubular acidosis (RTA types 1, 2, 4), rapid 0.9% saline expansion
  • •Acute toxic ingestions & prodromes: Antifreeze / ethylene glycol ingestion (flank pain, hematuria, oxalate crystals), methanol ingestion (visual blurriness, snowfield vision, optic papillitis), severe nausea, vomiting, abdominal pain, and progressive altered mental status

🩺 معاینه فیزیکی (Physical Exam):

  • •Kussmaul breathing: Classic respiratory compensation: deep, rapid, labored, hyperpneic respirations blowing off carbon dioxide to lower PaCO2; exhaustion of respiratory compensation heralds imminent catastrophic respiratory arrest
  • •Cardiovascular depression: Profound vasodilation, warm flushed skin progressing to mottled cold extremities, refractory hypotension unresponsive to high-dose vasopressors, diminished myocardial contractility, and ventricular arrhythmias
  • •Neurological sensorium: Lethargy, confusion, agitation, stupor, and deep metabolic coma; absence of focal neurological deficits unless toxic alcohol stroke (putaminal necrosis in methanol)

🧪 آزمایشگاه و تصویربرداری:

  • •Arterial Blood Gas & Delta-Delta Ratio: Stat ABG: arterial pH, PaCO2 (Winter formula for expected respiratory compensation: Expected PaCO2 = [1.5 x HCO3] + 8 +/- 2; if measured PaCO2 > expected, concurrent respiratory acidosis exists); Delta-Delta Ratio = (Anion Gap - 12) / (24 - HCO3); ratio < 0.8 indicates mixed HAGMA and NAGMA; ratio > 2.0 indicates concurrent metabolic alkalosis
  • •Osmolal Gap & Toxicology Diagnostics: Serum Osmolal Gap = Measured Serum Osmolality - Calculated Osmolality (Calculated = 2 x Na + Glucose/18 + BUN/2.8); Osmolal Gap > 10-15 mOsm/kg strongly indicates toxic alcohol poisoning (ethylene glycol, methanol, isopropanol); serum lactate, serum beta-hydroxybutyrate, serum salicylate level; urine microscopy for envelope-shaped or needle-shaped calcium oxalate crystals
  • •Comprehensive Metabolic Panel: Serum sodium, potassium (falsely elevated due to transcellular shift), chloride, bicarbonate, BUN, creatinine; calculate Bicarbonate Deficit = 0.5 x Body Weight (kg) x (Target HCO3 - Measured HCO3)

💊 دستورات بستری و درمانی (Generic INN):

  • ✓Diet/Activity: Strict NPO; bed rest with continuous ICU monitoring; elective endotracheal intubation must be approached with EXTREME CAUTION: mechanical ventilation must match the patient's massive spontaneous minute ventilation (high respiratory rate and tidal volume) to prevent acute catastrophic rise in PaCO2 and instant cardiac arrest
  • ✓Monitoring: Intensive Care Unit admission; continuous arterial line blood pressure monitoring; continuous ECG telemetry; continuous pulse oximetry; Foley catheter with hourly urine output; serial arterial blood gases, electrolytes, and anion gap every 1 to 2 hours until pH > 7.25; continuous central venous pressure monitoring
  • ✓IV Hydration: Resuscitate with balanced crystalloids (Plasma-Lyte) or isotonic sodium bicarbonate solutions; STRICTLY AVOID large-volume 0.9% Normal Saline (high chloride concentration 154 mEq/L induces severe hyperchloremic metabolic acidosis and renal vasoconstriction)
  • ✓Pharmacotherapy (Generic Only): ISOTONIC SODIUM BICARBONATE INFUSION PROTOCOL (Indicated for severe acidemia with pH < 7.10-7.15, severe uremic acidosis, or severe NAGMA): Formulate isotonic bicarbonate solution by adding Sodium Bicarbonate 150 mEq (three 50 mL 8.4% ampules) to 1000 mL 5% Dextrose in Water (D5W) infused at 150 to 250 mL/hr IV; TARGET: Raise arterial pH to 7.20-7.25 and bicarbonate to 12-15 mEq/L (do NOT attempt full normalization to 24 mEq/L acutely, which causes paradoxically worsened intracellular cerebral acidosis, hypocalcemia, and hypokalemia); CO-ADMINISTER POTASSIUM & CALCIUM: Monitor potassium and ionized calcium closely during bicarbonate infusion (bicarbonate shifts potassium intracellularly and reduces ionized calcium); TOXIC ALCOHOL SPECIFIC ANTIDOTE: Fomepizole 15 mg/kg IV loading dose over 30 minutes, followed by 10 mg/kg IV every 12 hours (inhibits alcohol dehydrogenase); if fomepizole unavailable, 10% Ethanol IV infusion; ADJUNCTIVE VITAMINS: Thiamine 100 mg IV daily, Pyridoxine 50 mg IV daily (for ethylene glycol), and Folinic acid (Leucovorin) 50 mg IV every 4 hours (for methanol); DEFINITIVE EMERGENCY HEMODIALYSIS: Immediate emergent hemodialysis indicated for: arterial pH < 7.10 refractory to therapy, ethylene glycol or methanol ingestion with high anion gap or visual symptoms, acute uremic renal failure, or severe refractory hyperkalemia

⚠️ علائم خطر حیات (Red Flags):

  • !Intubating a patient with severe metabolic acidosis and placing them on standard ventilator settings (e.g., rate 12-14), abruptly eliminating their compensatory Kussmaul hyperventilation and causing instant fatal acidemic cardiac arrest
  • !Administering rapid intravenous pushes of hypertonic 8.4% Sodium Bicarbonate in an inadequately ventilated patient, generating large amounts of CO2 which diffuses rapidly across the blood-brain barrier causing paradoxically lethal intracellular cerebral acidosis
  • !Failing to aggressively monitor and replace potassium and ionized calcium during bicarbonate infusion, precipitating severe tetany, seizures, and lethal hypokalemic ventricular fibrillation

ترومبوز حاد فیستول یا گرافت همودیالیز و عفونت باکتریمی مرتبط با کاتتر دیالیز

(Hemodialysis Arteriovenous Fistula/Graft Acute Thrombosis and Catheter-Related Bloodstream Infection)
ICD-10: T82.898Aمرجع: Brenner & Rector's The Kidney - Ch. 65

📋 نکات شرح حال (History Pearls):

  • •Acute vascular access failure: Sudden disappearance of the previously continuous vascular thrill and bruit over an autologous Arteriovenous Fistula (AVF) or prosthetic Arteriovenous Graft (AVG), accompanied by inability to cannulate or perform scheduled maintenance hemodialysis
  • •Catheter-Related Bloodstream Infection (CRBSI) presentation: Acute spiking fevers, shaking chills, rigors, diaphoresis, and hemodynamic instability developing during or immediately following a hemodialysis treatment session via a central venous catheter (tunneled or non-tunneled line)
  • •Precipitating and risk factors: Excessive ultrafiltration with intradialytic hypotension (MAP < 65 mmHg, triggering stagnant flow and acute thrombosis), external mechanical compression (sleeping on access arm, tight tourniquets/blood pressure cuffs), pre-existing venous anastomotic stenosis (intimal hyperplasia), hypercoagulability, or contaminated catheter hubs

🩺 معاینه فیزیکی (Physical Exam):

  • •Physical examination of AV Fistula / Graft: Palpation: absence of continuous palpable thrill (presence of a water-hammer pulse indicates complete downstream venous outflow obstruction; complete loss of pulse indicates inflow arterial or diffuse thrombosis); Auscultation: absence of continuous machinery-like low-pitched bruit (a high-pitched systolic-only bruit indicates significant localized stenosis); inspect for localized erythema, warmth, hematoma, or pseudoaneurysm
  • •Dialysis catheter exit site inspection: Inspect tunnel and exit site for purulent discharge, erythema > 2 cm, tenderness, cuff extrusion, or subcutaneous induration
  • •Systemic signs of septic shock: High fever (> 38.5 C) or hypothermia (< 36.0 C), profound resting tachycardia, tachypnea, hypotension, altered mental status, and metastatic septic emboli (Janeway lesions, Osler nodes, splinter hemorrhages, septic pulmonary emboli)

🧪 آزمایشگاه و تصویربرداری:

  • •Microbiology & Differential Time to Positivity (CRBSI): Paired quantitative blood cultures drawn simultaneously: one set from the dialysis catheter lumens and one set from a peripheral vein prior to antibiotic administration; CRBSI confirmed if catheter culture turns positive >= 2 hours earlier than peripheral culture (Differential Time to Positivity) or colony count is >= 3-fold higher from catheter; Staphylococcus aureus and coagulase-negative staphylococci account for > 60-70% of infections
  • •Urgent Color Doppler Ultrasonography: Duplex ultrasound of the vascular access evaluating luminal diameter, absence of flow or echogenic intraluminal thrombus, peak systolic velocities, and detection of underlying anatomical stenoses (juxta-anastomotic stenosis, cephalic arch stenosis, central vein stenosis)
  • •Systemic Inflammatory & Metabolic Workup: Complete blood count (marked leukocytosis with left shift or leukopenia); elevated C-Reactive Protein and procalcitonin; missed dialysis metabolic derangements: severe hyperkalemia (K+ > 6.0 mEq/L), severe azotemia (BUN > 100 mg/dL), and volume overload

💊 دستورات بستری و درمانی (Generic INN):

  • ✓Diet/Activity: Strict limb alert: NO venipunctures, NO peripheral IV lines, and NO blood pressure cuffs on the access extremity; strict potassium and fluid restriction while hemodialysis is interrupted; bed rest
  • ✓Monitoring: Intensive Care Unit or Step-Down monitoring if septic shock or severe hyperkalemia; continuous cardiac telemetry; blood pressure every 15-30 minutes; strict surveillance for metastatic septic complications (urgent transthoracic and transesophageal echocardiography to rule out infective endocarditis in all S. aureus CRBSI); serial potassium and blood gases every 4-6 hours
  • ✓IV Hydration: Avoid excessive crystalloid administration in anuric dialysis patients; if septic shock, administer cautious crystalloid boluses (250-500 mL) to maintain Mean Arterial Pressure >= 65 mmHg while monitoring closely for acute pulmonary edema; initiate Norepinephrine infusion if shock persists
  • ✓Pharmacotherapy (Generic Only): THROMBOSED AVF/AVG MANAGEMENT: Immediate vascular surgery or interventional radiology referral for urgent Percutaneous Mechanical Thrombectomy, Pharmacomechanical Thrombolysis (Alteplase 2 to 4 mg injected directly into thrombus), or surgical thromboembolectomy and patch angioplasty within 24 to 48 hours (delays beyond 48-72 hours drastically reduce salvage rates); EMPIRIC BROAD-SPECTRUM ANTIMICROBIALS FOR DIALYSIS CRBSI (Initiate immediately within 1 hour): Vancomycin 20 to 25 mg/kg IV loading dose (subsequent doses 500-1000 mg IV dosed post-hemodialysis guided by pre-dialysis trough levels 15-20 mcg/mL) PLUS Gentamicin 1 to 2 mg/kg IV single post-dialysis dose OR Cefepime 1 to 2 g IV post-hemodialysis (covers MRSA, MSSA, and gram-negative bacilli such as Pseudomonas and Enterobacteriaceae); ANTIMICROBIAL CATHETER LOCK SOLUTION: Instill catheter lock solution (Vancomycin 5 mg/mL plus Heparin 1000 units/mL or Gentamicin 5 mg/mL) into catheter lumens if catheter salvage attempted; CATHETER REMOVAL MANDATE: Immediate emergent catheter removal is MANDATORY for: severe sepsis / septic shock, Staphylococcus aureus bacteremia, Pseudomonas aeruginosa bacteremia, Candida / fungal infection, tunnel or pocket abscess, metastatic infection (endocarditis, septic arthritis, osteomyelitis), or persistent bacteremia > 48-72 hours despite appropriate antibiotics; TEMPORARY DIALYSIS RESCUE ACCESS: Placement of a new temporary non-tunneled dialysis catheter at a different anatomical site (contralateral internal jugular vein or femoral vein) to resume life-saving hemodialysis

⚠️ علائم خطر حیات (Red Flags):

  • !Attempting to salvage an infected hemodialysis catheter in the presence of Staphylococcus aureus, Pseudomonas, or fungal bacteremia, resulting in endocarditis, metastatic abscesses, and fatal sepsis
  • !Delaying the intervention for an acutely thrombosed arteriovenous fistula beyond 24 to 48 hours, converting a salvageable access into an irreversibly fibrosed, lost vascular lifeline
  • !Failing to perform transesophageal echocardiography in dialysis patients with catheter-associated Staphylococcus aureus bacteremia, missing occult destructive infective endocarditis